ArticleJournal for immunotherapy of cancer2018

The impact of PD-L1 on survival and value of the immune check point inhibitors in non-small-cell lung cancer; proposal, policies and perspective.

Helmy M GuirgisPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.